IFITM 1 (11p15.5) 
https://www.ncbi.nlm.nih.gov/gene/8519
- Official
                         Symbol
 
- IFITM1
 
-  Official
                         Full Name
 
- interferon induced transmembrane protein 1provided by HGNC
 
- Also known as
 
- 9-27; CD225; IFI17; LEU13; DSPA2a
 
- Expression
 
- Ubiquitous expression in spleen (RPKM 191.9), endometrium (RPKM 153.8) and 24 other tissues See more
 
- Orthologs
 
- Preferred Names
 
- interferon-induced transmembrane protein 1
 
- Names
 
- dispanin subfamily A member 2a
 - interferon-induced protein 17
 - interferon-inducible protein 9-27
 - leu-13 antigen
 
 
 
-  Strucutre: 1-125 aminoacids.
 
- TM 87..107.  
 
- https://www.ncbi.nlm.nih.gov/protein/NP_003632.3 
 
-  
 
- 
        Inhibiting
 of Proliferation, Migration, and Invasion in Lung Cancer Induced by 
Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1).
         Yan J, et al. Biomed Res Int, 2019. PMID 31205947, Free PMC Article
      
 
- 
        Prognostic
 significance of IFITM1 expression and correlation with microvessel 
density and epithelial-mesenchymal transition signature in lung 
adenocarcinoma.
         Koh YW, et al. Pathol Res Pract, 2019 Jul. PMID 31079850
      
 
- 
        Interferon-induced
 transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential 
for progression of non-small cell lung cancer.
         Yang YG, et al. Int J Cancer, 2019 Apr 15. PMID 30318841, Free PMC Article
      
 
- 
        IFITM1 expression is crucial to gammaherpesvirus infection, in vivo.
         Hussein HAM, et al. Sci Rep, 2018 Sep 20. PMID 30237526, Free PMC Article
      
 
- 
        Combination of IFITM1 knockdown and radiotherapy inhibits the growth of oral cancer.
         Yang J, et al. Cancer Sci, 2018 Oct. PMID 29770536, Free PMC Article
      
 
-  
 
- 
          In
 lung adenocarcinoma, IFITM1 was an independent prognostic factor for 
overall survival. Furthermore, high IFITM1 expression was significantly 
correlated with decreased overall survival rates in each pTNM stage.
          
        
 
- 
          study revealed the role of IFITM1 as a tumor promoter during lung cancer development and the possible molecular mechanism.
          
        
 
- 
          These studies identify a novel role for IFITM1, 2, and 3 in inhibiting HIV replication at the level of translation.
          
        
 
- 
          Silencing
 IFITM1 expression using siRNA specifically lowered gammaherpesvirus 
infection of cells at a post binding stage of entry.
          
        
 
- 
          These
 results demonstrate that constitutive upregulation of PITX2/IFITM1 
cascade is an intrinsic adaptive mechanism during the pathogenesis of 
letrozole-resistance, and modulation of PITX2/IFITM1 level using 
different genetic and pharmacological means would thus have a novel 
therapeutic potential against letrozole resistance in BCa.
          
        
 
- 
          Using
 non-small cell lung cancer (NSCLC) cell lines and patient-derived 
samples, study shows that IFITM1 is essentially required for the 
progression of NSCLC. IFITM1 depletion resulted in a significant 
reduction in sphere formation, migration, and invasion of NSCLC cells in
 vitro. High level of IFITM1 expression is associated with a poor 
overall survival rate in adenocarcinoma but not in squamous cell 
carcinoma.
          
        
 
- 
          overexpression
 of IFITM1, 2 and 3 suppressed entry of CXCR4 and CCR5 tropic viruses; 
entry of transmitted founder HIV-1 in U87 cells is more sensitive to 
inhibition by IFITM2 and IFITM3 than by IFITM1
          
        
 
- 
          High IFITM1 expression is associated with lymph node metastasis and invasion in Gallbladder Adenocarcinomas
          
        
 
- 
          Strong ifitm1 Expression in CD4 T Cells in HIV Controllers Is Correlated With Immune Activation
          
        
 
- 
          Using
 a multi-group heat map from GSE9716 analysis of the GEO database, 
IFITM1 was determined to be a relevant radioresistance gene. Inhibition 
of IFITM1 in combination with radiotherapy could, indeed, inhibit oral 
neoplasm cells.
 
 
 
 
          
      
 
  
 
 
 
 
 
 
 
 
 
 
 
Inga kommentarer:
Skicka en kommentar